Acme Bioscience, Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- acmeca.com
- Founded
- 2001
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Materials
- Chemicals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Acme bioscience, INC.:1273348 [16-009460] | NIH Clinical Center | $9,500 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| The Leland Stanford Junior University | 75N93020C00054 | $186,400 | |
| The Leland Stanford Junior University | 75N93020C00054 | $245,200 | |
| The Leland Stanford Junior University | 75N93020C00054 | $116,575 |
Similar vendors
About the company
Acme Bioscience, Inc., doing business as Acme Bioscience Inc., is a for-profit corporate entity registered to receive federal contract awards since February 10, 2015. The company specializes in providing synthetic organic chemistry services to the federal government, particularly in the field of medicinal chemistry and drug discovery. Acme Bioscience's expertise lies in custom synthesis, library generation, medicinal chemistry, and computational chemistry. Their services are primarily utilized in research projects aimed at developing novel compounds for potential therapeutic applications.
Based on their federal contract sub-award history, Acme Bioscience has been involved in several projects in collaboration with The Leland Stanford Junior University. These projects focus on the synthesis of chemicals designed by Stanford medicinal chemists, particularly in the area of PI4K inhibitors. The company's work includes synthesizing focused compound libraries, typically ranging from 20 to 200 compounds per library, on scales of 10-50 mg with a purity of >95%. They also provide analytical data, including 1H and 13C NMR and LCMS. Acme Bioscience is capable of scaling up production for advanced in-vivo studies, synthesizing compounds on a scale of 5-50 g with purities of 95% or higher. Their expertise in devising chemical synthetic routes when necessary has made them a valuable partner in federal research initiatives, particularly those funded through the National Institutes of Health, as evidenced by the contract numbers beginning with "75N93020C00054".
Quick answers
Is Acme Bioscience, Inc. registered in SAM.gov?
Acme Bioscience, Inc.'s SAM.gov registration expired on May 8, 2026.
What is Acme Bioscience, Inc.'s CAGE code?
Acme Bioscience, Inc.'s CAGE code is 57CZ7, and its Unique Entity ID (UEI) is JLADHHRK2K32.
What is Acme Bioscience, Inc.'s most recent federal award?
Acme Bioscience, Inc.'s most recent federal contract award is Acme bioscience, INC.:1273348 [16-009460] (HHSN269201600385P), from NIH Clinical Center, on April 7, 2016.
On GovTribe
See Acme Bioscience, Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors